Zurich Cantonal Bank Portfolio holdings
AUM
$40.9B
1-Year Return
22.88%
This Quarter Return
+4.99%
1 Year Return
+22.88%
3 Year Return
+106.76%
5 Year Return
+189.8%
10 Year Return
+428.78%
AUM
$30.7B
AUM Growth
+$2.2B
(+7.7%)
Cap. Flow
+$1.33B
Cap. Flow
% of AUM
4.32%
Top 10 Holdings %
Top 10 Hldgs %
34.82%
Holding
2,761
New
46
Increased
1,356
Reduced
554
Closed
111
Top Buys
| 1 |
UBS Group
UBS
|
$162M |
| 2 |
Microsoft
MSFT
|
$102M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$99.6M |
| 4 |
Apple
AAPL
|
$89.7M |
| 5 |
Amazon
AMZN
|
$88.7M |
Top Sells
| 1 |
Adobe
ADBE
|
$51.8M |
| 2 |
Texas Instruments
TXN
|
$48.2M |
| 3 |
Merck
MRK
|
$47.8M |
| 4 |
Chevron
CVX
|
$42.1M |
| 5 |
Netflix
NFLX
|
$30.8M |
Sector Composition
| 1 | Technology | 30.54% |
| 2 | Financials | 15.57% |
| 3 | Healthcare | 13.56% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Hyster-Yale Materials Handling
HY
$668M
| $23.4K | ﹤0.01% |
336
| – | – |
|
2527
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $23.4K | ﹤0.01% |
13,534
-1,988
| -13% | -$3.44K |
|
2528
Biomea Fusion
BMEA
$114M
| $21.3K | ﹤0.01% |
4,744
| – | – |
|
2529
Arbutus Biopharma
ABUS
$805M
| $21K | ﹤0.01% |
6,780
-101
| -1% | -$312 |
|
|
THRD
2530
DELISTED
Third Harmonic Bio
THRD
| $20.4K | ﹤0.01% |
1,571
-32
| -2% | -$416 |
|
|
CNTA
2531
Centessa Pharmaceuticals
CNTA
$2.11B
| $20.2K | ﹤0.01% |
2,234
-33
| -1% | -$298 |
|
2532
Scilex Holding
SCLX
$159M
| $19.5K | ﹤0.01% |
289
-3
| -1% | -$203 |
|
2533
Ascendis Pharma
ASND
$12.5B
| $19K | ﹤0.01% |
139
-3
| -2% | -$409 |
|
2534
Dole
DOLE
$1.29B
| $18.4K | ﹤0.01% |
1,506
| – | – |
|
2535
Mobileye
MBLY
$12B
| $17.7K | ﹤0.01% |
631
-3,057
| -83% | -$85.9K |
|
2536
KalVista Pharmaceuticals
KALV
$796M
| $16.9K | ﹤0.01% |
1,436
-64
| -4% | -$754 |
|
2537
Frontier Group Holdings
ULCC
$1.18B
| $16.7K | ﹤0.01% |
3,389
| – | – |
|
2538
908 Devices
MASS
$196M
| $16.2K | ﹤0.01% |
3,145
-495
| -14% | -$2.55K |
|
2539
Angi Inc
ANGI
$811M
| $16.2K | ﹤0.01% |
843
| – | – |
|
|
SLSR
2540
Solaris Resources
SLSR
$857M
| $15.9K | ﹤0.01% |
+5,710
| New | +$15.9K |
|
2541
AC Immune
ACIU
$229M
| $15.4K | ﹤0.01% |
3,851
-68
| -2% | -$271 |
|
2542
Fulcrum Therapeutics
FULC
$414M
| $15.3K | ﹤0.01% |
2,475
-7
| -0.3% | -$43 |
|
2543
ATN International
ATNI
$245M
| $15.3K | ﹤0.01% |
671
| – | – |
|
|
JKS
2544
JinkoSolar
JKS
$1.32B
| $15K | ﹤0.01% |
723
-77
| -10% | -$1.6K |
|
2545
uniQure
QURE
$985M
| $14.6K | ﹤0.01% |
3,260
-431
| -12% | -$1.93K |
|
2546
British American Tobacco
BTI
$122B
| $14.6K | ﹤0.01% |
472
+248
| +111% | +$7.67K |
|
2547
Codexis
CDXS
$218M
| $13.6K | ﹤0.01% |
4,386
-12,618
| -74% | -$39.1K |
|
2548
Pluri
PLUR
$39.5M
| $13.2K | ﹤0.01% |
2,276
-359
| -14% | -$2.08K |
|
|
DQ
2549
Daqo New Energy
DQ
$1.96B
| $12.9K | ﹤0.01% |
883
-49
| -5% | -$715 |
|
2550
Mesa Laboratories
MLAB
$356M
| $12.8K | ﹤0.01% |
148
| – | – |
|